March 28 (Reuters) – A U.S. district court on Monday ruled in favor of Shire Plc, preventing Allergan Plc from selling generic versions of Lialda, the ulcerative colitis drug, in the United States…
The post Shire gets favorable ruling against Allergan in Lialda patent case appeared first on NASDAQ.